OnPoint Surgical Appoints Jeremy Laynor as CCO to Propel Global Expansion of AR-AI Technology

OnPoint Surgical, Inc., a frontrunner in the realm of Augmented Reality (AR) and Artificial Intelligence (AI) technologies for spinal surgeries, recently made headlines with the appointment of Jeremy Laynor as Chief Commercial Officer (CCO). This strategic decision is envisioned to accelerate the company's growth on an international scale.

With over 20 years of invaluable experience in the medical device and healthcare technology sectors, Laynor brings a wealth of expertise that has been honed in both Fortune 100 companies and dynamic startups. His history of scaling operations and driving revenue growth speaks to his capability. Most recently, Laynor served as the Senior Vice President of Global Sales at Providence Medical Technology, where he notably increased revenue through the leadership of a high-performing sales team and an extensive international distribution network.

Before this, Laynor's senior roles at notable companies like Paradigm Spine, Medtronic, and Cardinal Health involved pioneering sales strategies and enhancing surgeon education programs, as well as creating innovative marketing models tailored for ambulatory surgery centers. His unique career trajectory began in sports and corporate sponsorship sales, which positions him well in fostering customer engagement and building strategic brand partnerships.

Philipp Lang, M.D., the CEO of OnPoint Surgical, expressed enthusiastic support for Laynor’s appointment, stating, "Jeremy is an exceptional commercial leader whose deep expertise in orthopedic and spine markets will be transformative for OnPoint. His ability to scale global sales operations will be critical as we advance the commercialization of our AR-AI surgical guidance systems."

In response, Laynor articulated his excitement about joining OnPoint, emphasizing the significance of its AR-AI technology in reshaping surgical practices regarding precision, safety, and efficiency. He views the company's groundbreaking innovations as vital in not only enhancing surgeon capabilities but also in significantly benefiting patients.

OnPoint’s AR-AI technology is developed with numerous applications ranging from spinal procedures to orthopedic interventions, with a robust intellectual property framework protected by over 50 patents across the U.S., China, and the European Union. This proprietary approach positions OnPoint uniquely within the medical technology sector, enabling them to define the future of surgical navigation and intervention.

The anticipation surrounding the global expansion of OnPoint's offerings under Laynor's leadership signifies not only a commitment to advancing technology in healthcare but also highlights the company’s ambition to broaden its reach into various surgical applications within the medical field. As the sector continues to evolve, OnPoint's strategic moves aim to consolidate its position as a pioneer in medical innovation.

For more detailed information about OnPoint Surgical, interested parties can visit their official website at www.onpointar.ai. With exciting developments on the horizon, the entire medical community will be watching closely as OnPoint strives to enhance surgical outcomes worldwide through its cutting-edge technology.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.